Mayme Lou Roettig, RN, MSN
Executive Medical Director
Ms. Roettig is our Executive Medical Director. She brings 30 years of experience in the cardiovascular domain that spans from clinical nursing practice to cardiovascular research and education. She has been a leader and change agent bringing evidence-based research into practice to impact patient outcomes. Ms. Roettig held clinical nurse positions in large US medical centers in coronary and critical care units, medical telemetry units, and interventional cardiac catheterization labs. In addition, she served as an advanced practice nurse in cardiology clinics. Trained as a cardiovascular clinical nurse specialist, Ms. Roettig has spent most of her career in research and education. Her research career spans working in early phase to large phase 3 clinical development trials to focusing on outcomes research. Specifically, she focused on quality initiatives and implementation science to improve process and clinical outcomes for the cardiovascular patient.
Ms. Roettig worked in multiple leadership roles within Biotechnology at the Genentech, Inc. cardiovascular franchise during the fibrinolysis era for Myocardial Infarction and Acute Ischemic Stroke from 1996 to 2004. Ms. Roettig was instrumental as a pioneer in some of the early ST-Elevation Myocardial Infarction quality improvement and systems of care work that changed how the US healthcare system responded to patients experiencing acute coronary syndrome symptoms. Ms. Roettig worked for the Duke Clinical Research Institute, Duke University, in various leadership roles from 2005 to 2019, including Executive Director of the RACE Campaigns in ST-Elevation Myocardial Infarction and Cardiac Arrest, Assistant Director for the Center of Educational Excellence developing the Accelerator and IMPACT AF studies, and as the Operations Director of Health Systems and Implementation Science in Health Services Research initiating the IMPROVE Stroke Care and COORDINATE Diabetes studies. Ms. Roettig served as the National Director for the American Heart Association for their flagship Mission: Lifeline Initiative as staff spokeswoman. She also worked alongside the volunteer leadership teams at AHA to improve emergency response in ST-Elevation Myocardial Infarction from 2008 to 2010 and continued as a volunteer leader through 2016.
Before joining PLx Pharma, Ms. Roettig worked for IQVIA, Inc. North America Real World Solutions from 2019 to 2021. Making sure the patient receives evidence-based emergency care and remains adherent to secondary prevention and healthy lifestyle changes after a CV event has been a lifetime passion of hers and she remains centered on patient outcomes. Ms. Roettig is an author or co-author in 25 peer-reviewed publications. She received her undergraduate Associate Degree of Nursing and Bachelor of Science of Nursing from the University of Charleston and her Master of Science in Nursing from Loyola University of Chicago.